Massachusetts Financial Services’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-68,329
Closed -$1.75M 839
2023
Q2
$1.75M Sell
68,329
-1,609
-2% -$42.4K ﹤0.01% 721
2023
Q1
$2.08M Sell
69,938
-1,979
-3% -$57.5K ﹤0.01% 711
2022
Q4
$1.95M Buy
71,917
+1,521
+2% +$37.2K ﹤0.01% 731
2022
Q3
$1.53M Buy
70,396
+9,035
+15% +$236K ﹤0.01% 751
2022
Q2
$1.68M Buy
61,361
+309
+0.5% +$8.88K ﹤0.01% 742
2022
Q1
$2.04M Buy
61,052
+626
+1% +$20.2K ﹤0.01% 750
2021
Q4
$2.1M Sell
60,426
-10,805
-15% -$349K ﹤0.01% 774
2021
Q3
$2.22M Buy
71,231
+19,758
+38% +$670K ﹤0.01% 773
2021
Q2
$1.87M Buy
51,473
+441
+0.9% +$18.2K ﹤0.01% 787
2021
Q1
$2.23M Sell
51,032
-6,049
-11% -$284K ﹤0.01% 758
2020
Q4
$2.62M Sell
57,081
-579
-1% -$24.1K ﹤0.01% 708
2020
Q3
$1.92M Sell
57,660
-2,257
-4% -$72.1K ﹤0.01% 721
2020
Q2
$1.76M Sell
59,917
-1,535
-2% -$44.4K ﹤0.01% 697
2020
Q1
$1.66M Buy
61,452
+9,726
+19% +$290K ﹤0.01% 699
2019
Q4
$1.74M Sell
51,726
-12,940
-20% -$469K ﹤0.01% 726
2019
Q3
$2.42M Buy
64,666
+7,213
+13% +$275K ﹤0.01% 705
2019
Q2
$2.5M Buy
57,453
+8,005
+16% +$342K ﹤0.01% 708
2019
Q1
$2.11M Buy
49,448
+1,829
+4% +$81.9K ﹤0.01% 712
2018
Q4
$2.13M Buy
47,619
+3,706
+8% +$194K ﹤0.01% 702
2018
Q3
$3.01M Sell
43,913
-101
-0.2% -$6.5K ﹤0.01% 694
2018
Q2
$2.52M Buy
44,014
+2,670
+6% +$141K ﹤0.01% 702
2018
Q1
$1.91M Buy
41,344
+639
+2% +$30.3K ﹤0.01% 705
2017
Q4
$1.88M Buy
40,705
+5,711
+16% +$262K ﹤0.01% 709
2017
Q3
$1.58M Buy
+34,994
New +$1.49M ﹤0.01% 713
2015
Q4
Sell
-17,227
Closed -$490K 849
2015
Q3
$490K Sell
17,227
-276
-2% -$9.63K ﹤0.01% 821
2015
Q2
$709K Sell
17,503
-313
-2% -$14K ﹤0.01% 798
2015
Q1
$877K Buy
+17,816
New +$825K ﹤0.01% 790

Other funds holding AVNS